Cover ImageSALE
市場調查報告書

遺傳基因檢驗的全球市場:2018年∼2022年

Global Genetic Testing Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 276812
出版日期 內容資訊 英文 140 Pages
訂單完成後即時交付
價格
Back to Top
遺傳基因檢驗的全球市場:2018年∼2022年 Global Genetic Testing Market 2018-2022
出版日期: 2018年02月21日 內容資訊: 英文 140 Pages
簡介

Technavio的市場分析師預測,全球遺傳基因檢驗市場至2022年將以10%以上的年複合成長率踏實成長。

本報告提供產品類型(分析設備,消耗品)和應用(預測、診斷檢驗,產前、新生兒、胚胎著床前檢驗,藥理基因試驗,法醫學、父母和子女關係、祖先檢驗)為基礎全球遺傳基因檢驗市場全面的分析。還有也包含地區(美國,APAC,EMEA)為基礎分析。

本報告處理的項目

  • 2022年的市場規模與成長率
  • 促進全球遺傳基因檢驗市場成長的主要原因
  • 全球遺傳基因檢驗市場影響成長主要市場趨勢
  • 市場成長的課題
  • 全球遺傳基因檢驗市場上主要供應商
  • 全球遺傳基因檢驗市場上供應商面臨的市場機會和威脅
  • 影響南北美洲、APAC、EMEA的市場佔有率的趨勢係數
  • 全球遺傳基因檢驗市場波特的五力分析的主要結果

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模
  • 市場規模及預測

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 市場區隔:各應用領域

  • 概要
  • 預測檢驗、診斷檢驗
  • 產前、新生兒、胚胎著床前檢驗
  • 藥理基因學檢驗
  • 法醫學、父母和子女關係、祖先檢驗

第8章 市場區隔:各產品

  • 概要
  • 比較:各產品
  • 分析設備
  • 消耗品
  • 市場機會:各產品

第9章 客戶形勢

第10章 分割:各終端用戶

  • 概要
  • 臨床診斷研究所
  • 醫院
  • 生物醫藥品企業及研究中心

第11章 地區形勢

  • 各地區市場區隔
  • 地區比較
  • 遺傳基因檢驗市場:南北美洲
  • 遺傳基因檢驗市場:歐洲、中東、非洲地區
  • 遺傳基因檢驗市場:亞太地區
  • 市場機會

第12章 決策架構

第13章 成長要素與課題

  • 市場成長要素
  • 市場課題

第14章 市場趨勢

  • 搭配診斷需求高漲
  • 現在及未來的遺傳基因診斷用的NGS的利用可能性
  • DTC遺傳基因檢驗的採用的擴大

第15章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭情形

第16章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Myriad Genetics
  • QIAGEN
  • Quest Diagnostics

第17章 附錄

  • 簡稱清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR21575

This industry research report presents a detailed analysis of the genetic testing market by product type (analyzers and consumables) and by application (predictive and diagnostic testing, prenatal, newborn, and pre-implantation testing, pharmacogenomic testing, and forensic, relationship, and ancestry testing). This report also presents an analysis based on geography (the Americas, APAC, and EMEA).

Our market analysts estimate that the market will grow steadily at a CAGR of greater than 10% by 2022.

Key questions answered in the report include:

  • What will the market size and the growth rate be in 2022?
  • What are the key factors driving the global genetic testing market?
  • What are the key market trends impacting the growth of the global genetic testing market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global genetic testing market?
  • What are the market opportunities and threats faced by the vendors in the global genetic testing market?
  • Trending factors influencing the market shares of the Americas, APAC, and EMEA.
  • What are the key outcomes of the five forces analysis of the global genetic testing market?

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: SEGMENTATION BY APPLICATION

  • Overview
  • Predictive and diagnostic testing
  • Prenatal, newborn, and pre-implantation testing
  • Pharmacogenomic testing
  • Forensic, relationship, and ancestry testing

PART 08: SEGMENTATION BY PRODUCT

  • Overview
  • Comparison by product
  • Analyzers
  • Consumables
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: SEGMENTATION BY END-USER

  • Overview
  • Clinical diagnostics laboratories
  • Hospitals
  • Biopharmaceuticals companies and research centers

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Genetic testing market in Americas
  • Genetic testing market in EMEA
  • Genetic testing market in APAC
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

  • Growing demand for companion diagnostics
  • Availability of NGS for present and future genetic diagnosis
  • Growing adoption of DTC genetic testing

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive landscape

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • bioMerieux
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Myriad Genetics
  • QIAGEN
  • Quest Diagnostics

PART 17: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market: Global IVD market
  • Exhibit 02: Global IVD market: Segments
  • Exhibit 03: Market characteristics
  • Exhibit 04: Global genetic testing market: Segments
  • Exhibit 05: Market definition: Inclusions and exclusions checklist
  • Exhibit 06: Global genetic testing market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global genetic testing market 2017-2022 ($ millions)
  • Exhibit 09: Global genetic testing market: Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition: Five forces 2017
  • Exhibit 18: Global genetic testing market: Segmentation by application 2017 (% share)
  • Exhibit 19: Global genetic testing market: Segmentation by product 2017-2022 (% share)
  • Exhibit 20: Global genetic testing market: Comparison by product
  • Exhibit 21: Global genetic testing analyzers market 2017-2022 ($ millions)
  • Exhibit 22: Global genetic testing analyzers market: Year-over-year growth 2018-2022 (%)
  • Exhibit 23: Global genetic testing consumables market 2017-2022 ($ millions)
  • Exhibit 24: Global genetic testing consumables market: Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Market opportunity by product
  • Exhibit 26: Customer landscape
  • Exhibit 27: Global genetic testing market: Segmentation by end-user 2017 (% share)
  • Exhibit 28: Global genetic testing market: Segmentation by geography 2017-2022 (% share)
  • Exhibit 29: Regional comparison
  • Exhibit 31: Genetic testing market in Americas 2017-2022 ($ millions)
  • Exhibit 32: Genetic testing market in Americas: Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top-three countries in Americas
  • Exhibit 34: Genetic testing market in EMEA 2017-2022 ($ millions)
  • Exhibit 35: Genetic testing market in EMEA: Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top-three countries in EMEA
  • Exhibit 37: Genetic testing market in APAC 2017-2022 ($ millions)
  • Exhibit 38: Genetic testing market in APAC: Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Top-three countries in APAC
  • Exhibit 40: Market opportunity
  • Exhibit 41: Product approvals in few countries and their market impact analysis
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Abbott: Overview
  • Exhibit 48: Abbott: Business segments
  • Exhibit 49: Abbott: Organizational developments
  • Exhibit 50: Abbott: Geographic focus
  • Exhibit 51: Abbott: Segment focus
  • Exhibit 52: Abbott: Key offerings
  • Exhibit 53: Abbott: Key customers
  • Exhibit 54: bioMerieux: Overview
  • Exhibit 55: bioMerieux: Business segments
  • Exhibit 56: bioMerieux: Organizational developments
  • Exhibit 57: bioMerieux: Geographic focus
  • Exhibit 58: bioMerieux: Segment focus
  • Exhibit 59: bioMerieux: Key offerings
  • Exhibit 60: bioMerieux: Key customers
  • Exhibit 61: Bio-Rad Laboratories: Overview
  • Exhibit 62: Bio-Rad Laboratories: Business segments
  • Exhibit 63: Bio-Rad Laboratories: Organizational developments
  • Exhibit 64: Bio-Rad Laboratories: Geographic focus
  • Exhibit 65: Bio-Rad Laboratories: Segment focus
  • Exhibit 66: Bio-Rad Laboratories: Key offerings
  • Exhibit 67: Bio-Rad Laboratories: Key customers
  • Exhibit 68: F. Hoffmann-La Roche: Overview
  • Exhibit 69: F. Hoffmann-La Roche: Business segments
  • Exhibit 70: F. Hoffmann-La Roche: Organizational developments
  • Exhibit 71: F. Hoffmann-La Roche: Geographic focus
  • Exhibit 72: F. Hoffmann-La Roche: Segment focus
  • Exhibit 73: F. Hoffmann-La Roche: Key offerings
  • Exhibit 74: F. Hoffmann-La Roche: Key customers
  • Exhibit 75: Myriad Genetics: Overview
  • Exhibit 76: Myriad Genetics: Business segments
  • Exhibit 77: Myriad Genetics: Organizational developments
  • Exhibit 78: Myriad Genetics: Geographic focus
  • Exhibit 79: Myriad Genetics: Segment focus
  • Exhibit 80: Myriad Genetics: Key offerings
  • Exhibit 81: Myriad Genetics: Key customers
  • Exhibit 82: QIAGEN: Overview
  • Exhibit 83: QIAGEN: Product categories
  • Exhibit 84: QIAGEN: Organizational developments
  • Exhibit 85: QIAGEN: Geographic focus
  • Exhibit 86: QIAGEN: Product categories focus
  • Exhibit 87: QIAGEN: Key offerings
  • Exhibit 88: QIAGEN: Key customers
  • Exhibit 89: Quest Diagnostics: Overview
  • Exhibit 90: Quest Diagnostics: Business segments
  • Exhibit 91: Quest Diagnostics: Organizational developments
  • Exhibit 92: Quest Diagnostics: Geographic focus
  • Exhibit 93: Quest Diagnostics Segment focus
  • Exhibit 94: Quest Diagnostics Key offerings
  • Exhibit 95: Quest Diagnostics: Key customers
Back to Top